An oral norovirus vaccine stimulates systemic and mucosal immune responses that predict protection against infection in a phase 2 challenge study.
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study | Science Translational Medicine
